Kestine (Ebastine)

Ebastine selectively blocks peripheral H1 receptors, preventing histamine from triggering the cascade that leads to vasodilation, increased vascular permeability, and sensory nerve activation. This inhibition reduces typical allergic symptoms without significant central nervous system penetration.

The appropriate dose of Kestine is determined by the prescribing healthcare professional based on the patient’s age, condition severity, and renal or hepatic function. Dosage instructions are provided on the prescription label and should be followed exactly as directed.

Safety data for ebastine in pregnancy and lactation are limited. It should only be used if the potential benefit outweighs any possible risk to the fetus or infant. Women who are pregnant, planning pregnancy, or breastfeeding should discuss alternatives with their clinician.

To request Kestine, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Compared with first‑generation antihistamines, ebastine (Kestine) offers effective allergy relief with a lower risk of sedation and anticholinergic effects. It is similar in efficacy to other second‑generation agents such as cetirizine or loratadine, but individual response and tolerability may vary.

Kestine should be stored at ambient temperature, preferably below 25 °C. Keep the tablets in the original packaging, protect them from moisture and direct sunlight, and ensure they are out of reach of children.

Kestine is taken orally, usually with a glass of water. It can be taken with or without food, but consistency with regard to meals may help maintain stable absorption. Follow the prescribing clinician’s instructions for timing and frequency.

Although rare, serious adverse events may include cardiac arrhythmias such as QT prolongation, severe skin reactions like Stevens‑Johnson syndrome, and anaphylactic hypersensitivity. Patients should seek immediate medical attention if they experience palpitations, rash, or signs of an allergic reaction.

Kestine is contraindicated in individuals with known hypersensitivity to ebastine or any of the tablet excipients. Caution is advised for patients with severe hepatic impairment, known cardiac conduction disorders, or those taking strong CYP3A4 inhibitors.